|

Ixekizumab Clinical Trials

2 actively recruiting trials

Also known as: N/A (Not applicable), Taltz

Pipeline

Phase 2: 1

Top Sponsors

  • NHS Greater Glasgow and Clyde1
  • Göteborg University1

Indications

  • Psoriatic Plaque1
  • Type1 Diabetes Mellitus1
  • Psoriatic Arthritis1
  • Depression1
  • Arthritis1

Other2 trials

Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
Ixekizumab Diabetes Intervention Trial (I-DIT)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.